Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Petter Bjornstad

Concepts (398)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
78
2025
294
24.260
Why?
Diabetes Mellitus, Type 2
69
2025
2531
10.640
Why?
Diabetes Mellitus, Type 1
79
2025
3715
9.980
Why?
Glomerular Filtration Rate
64
2025
746
8.410
Why?
Kidney
51
2025
1468
6.060
Why?
Uric Acid
23
2022
163
4.640
Why?
Albuminuria
23
2024
185
4.190
Why?
Insulin Resistance
20
2024
1208
4.110
Why?
Renal Insufficiency, Chronic
21
2025
617
3.410
Why?
Hemodynamics
23
2025
1113
2.830
Why?
Pediatric Obesity
8
2023
601
2.780
Why?
Metformin
12
2025
331
2.760
Why?
Renal Insufficiency
6
2023
162
2.700
Why?
Coronary Artery Disease
11
2022
698
2.520
Why?
Diabetic Angiopathies
9
2019
259
2.420
Why?
Biomarkers
36
2025
4149
2.410
Why?
Glycopeptides
10
2021
43
2.250
Why?
Hypoglycemic Agents
22
2025
1291
2.180
Why?
Bariatric Surgery
5
2020
217
2.170
Why?
Vascular Calcification
6
2022
108
2.130
Why?
Obesity, Morbid
5
2020
264
2.100
Why?
Adolescent
66
2025
21513
2.010
Why?
Renin-Angiotensin System
10
2021
85
1.920
Why?
Sodium-Glucose Transporter 2
12
2024
24
1.890
Why?
Humans
172
2025
137585
1.730
Why?
Glucosides
11
2025
44
1.620
Why?
Sex Characteristics
6
2025
762
1.610
Why?
Creatinine
18
2025
499
1.610
Why?
Cardiovascular Diseases
15
2024
2111
1.590
Why?
Young Adult
47
2025
13209
1.580
Why?
Benzhydryl Compounds
11
2025
73
1.580
Why?
Diabetic Ketoacidosis
4
2025
201
1.460
Why?
Male
104
2025
67762
1.450
Why?
Disease Progression
19
2024
2757
1.400
Why?
Female
99
2025
73304
1.360
Why?
Calcinosis
4
2015
235
1.300
Why?
Obesity
12
2025
2992
1.230
Why?
Adult
59
2025
37929
1.190
Why?
Diabetic Cardiomyopathies
4
2020
36
1.160
Why?
Kidney Diseases
3
2023
408
1.160
Why?
Risk Factors
36
2024
10388
1.080
Why?
Hyperglycemia
6
2025
347
1.070
Why?
Child
35
2025
21935
1.060
Why?
Glucagon-Like Peptides
2
2025
58
1.050
Why?
Adiposity
5
2024
518
1.020
Why?
Follow-Up Studies
18
2025
5131
0.980
Why?
Arterioles
3
2024
52
0.970
Why?
Acute Kidney Injury
6
2025
815
0.970
Why?
Hypertension
9
2021
1295
0.970
Why?
Exercise Tolerance
3
2017
279
0.950
Why?
Fructose
4
2021
112
0.940
Why?
Atherosclerosis
4
2018
415
0.940
Why?
Apolipoproteins B
2
2015
43
0.930
Why?
Vascular Stiffness
7
2022
494
0.920
Why?
Uromodulin
3
2019
21
0.910
Why?
Body Composition
3
2025
684
0.910
Why?
Proteinuria
2
2024
97
0.910
Why?
Hyperuricemia
6
2021
44
0.900
Why?
Cross-Sectional Studies
19
2025
5472
0.890
Why?
Vasopressins
3
2023
64
0.890
Why?
Middle Aged
52
2025
33479
0.880
Why?
Immunoglobulin Fc Fragments
1
2024
41
0.880
Why?
Case-Control Studies
14
2025
3556
0.870
Why?
Adiponectin
2
2016
244
0.870
Why?
Blood Glucose
13
2025
2186
0.840
Why?
Prognosis
12
2025
4030
0.830
Why?
Hyperoxia
1
2024
90
0.810
Why?
Iothalamic Acid
1
2022
5
0.800
Why?
Dyslipidemias
5
2021
176
0.800
Why?
Kidney Tubules
2
2021
117
0.800
Why?
Diabetic Retinopathy
4
2021
189
0.790
Why?
Blood Pressure
10
2025
1786
0.770
Why?
Cystatin C
8
2023
65
0.760
Why?
Epithelial-Mesenchymal Transition
1
2024
209
0.760
Why?
Kidney Glomerulus
5
2023
119
0.730
Why?
Recombinant Fusion Proteins
1
2024
665
0.730
Why?
Bone Density
1
2025
489
0.700
Why?
Polycystic Kidney, Autosomal Dominant
1
2024
262
0.660
Why?
Oxygen Consumption
3
2017
696
0.650
Why?
Dried Blood Spot Testing
2
2018
104
0.640
Why?
Iohexol
2
2020
23
0.640
Why?
Triglycerides
3
2022
524
0.640
Why?
Kidney Failure, Chronic
4
2023
570
0.630
Why?
Oxygen
2
2024
931
0.630
Why?
Vascular Resistance
6
2020
375
0.620
Why?
Cyclic GMP
1
2019
93
0.610
Why?
Longevity
6
2022
165
0.610
Why?
Lipid Metabolism Disorders
1
2018
3
0.610
Why?
Pilot Projects
7
2024
1710
0.600
Why?
Coronary Vessels
3
2017
248
0.600
Why?
Cohort Studies
18
2025
5742
0.580
Why?
Weight Reduction Programs
1
2019
117
0.580
Why?
Gastric Bypass
1
2020
119
0.580
Why?
Leptin
2
2017
236
0.580
Why?
Cardiotonic Agents
1
2018
124
0.570
Why?
Overweight
3
2025
558
0.570
Why?
Hemofiltration
1
2018
30
0.570
Why?
Sodium Bicarbonate
1
2018
45
0.560
Why?
Cholesterol, HDL
2
2015
203
0.560
Why?
Glucose
5
2023
1020
0.550
Why?
Ventricular Function, Left
3
2020
534
0.540
Why?
Incidence
9
2021
2804
0.540
Why?
Blood Vessels
1
2018
187
0.540
Why?
Aorta
2
2019
417
0.530
Why?
Up-Regulation
2
2016
843
0.510
Why?
Nutrition Surveys
1
2017
266
0.500
Why?
Cholesterol, LDL
2
2014
365
0.490
Why?
Kidney Function Tests
4
2022
160
0.470
Why?
Renal Circulation
3
2021
58
0.470
Why?
Aged
30
2025
23961
0.460
Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.450
Why?
Pregnancy Outcome
1
2017
416
0.450
Why?
Canada
7
2022
418
0.450
Why?
Insulin
7
2025
2409
0.440
Why?
Body Mass Index
9
2025
2389
0.440
Why?
Sodium
5
2025
217
0.430
Why?
Fasting
2
2025
281
0.430
Why?
Echocardiography
2
2018
642
0.430
Why?
Hypoxia
2
2020
1112
0.430
Why?
Natriuresis
3
2025
15
0.430
Why?
Dietary Supplements
1
2018
561
0.420
Why?
Patient Care Planning
1
2014
157
0.410
Why?
Goals
1
2015
170
0.410
Why?
Drug Therapy, Combination
5
2025
1066
0.410
Why?
Brain
1
2025
2668
0.400
Why?
Vasoconstriction
3
2020
202
0.400
Why?
Chitinase-3-Like Protein 1
2
2022
19
0.390
Why?
Heart Failure
3
2021
2236
0.390
Why?
Histidine
2
2022
64
0.380
Why?
Contrast Media
1
2015
467
0.380
Why?
Lipids
2
2022
672
0.370
Why?
Age of Onset
2
2025
518
0.370
Why?
Glucose Clamp Technique
5
2020
195
0.360
Why?
Albumins
3
2022
114
0.350
Why?
Angiotensin II
3
2020
99
0.350
Why?
Clinical Trials as Topic
6
2022
1050
0.350
Why?
Guideline Adherence
1
2015
556
0.330
Why?
Absorptiometry, Photon
2
2025
259
0.330
Why?
Lipocalin-2
2
2022
79
0.330
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
445
0.320
Why?
Prospective Studies
9
2025
7604
0.310
Why?
Testosterone
3
2025
409
0.300
Why?
Running
2
2023
230
0.300
Why?
Pulse Wave Analysis
5
2022
272
0.290
Why?
Animals
16
2025
36940
0.280
Why?
Diabetes Complications
2
2021
227
0.280
Why?
Treatment Outcome
11
2025
10811
0.270
Why?
Epidermal Growth Factor
2
2024
177
0.270
Why?
Metabolic Syndrome
3
2021
354
0.270
Why?
Canagliflozin
3
2023
10
0.270
Why?
Heat Stress Disorders
2
2018
76
0.250
Why?
Dipeptidyl-Peptidase IV Inhibitors
3
2025
47
0.250
Why?
Glucagon-Like Peptide-1 Receptor
3
2021
82
0.250
Why?
Diabetes Mellitus
3
2021
1040
0.240
Why?
Severity of Illness Index
3
2021
2828
0.240
Why?
Age Factors
7
2019
3295
0.240
Why?
Double-Blind Method
4
2025
1993
0.240
Why?
Gliclazide
1
2025
2
0.240
Why?
Linagliptin
1
2025
5
0.240
Why?
Time Factors
6
2018
6828
0.240
Why?
Hydrogen-Ion Concentration
2
2018
560
0.240
Why?
Colorado
4
2017
4565
0.240
Why?
Leucine
2
2024
111
0.230
Why?
Fatty Acid Binding Protein 3
1
2024
6
0.230
Why?
Predictive Value of Tests
4
2018
2031
0.230
Why?
Vascular Cell Adhesion Molecule-1
1
2024
39
0.230
Why?
Early Diagnosis
2
2017
242
0.230
Why?
Citric Acid Cycle
1
2024
57
0.230
Why?
Glucagon-Like Peptide 1
2
2025
135
0.230
Why?
Gray Matter
1
2025
80
0.220
Why?
Renin
2
2022
35
0.220
Why?
Androgen Antagonists
1
2025
82
0.220
Why?
Estradiol
2
2025
521
0.220
Why?
Diuretics
2
2023
74
0.220
Why?
Lipoproteins
2
2022
168
0.220
Why?
Endothelin Receptor Antagonists
2
2024
62
0.220
Why?
Sex Factors
4
2025
2071
0.220
Why?
Mineralocorticoid Receptor Antagonists
2
2024
54
0.210
Why?
National Institutes of Health (U.S.)
1
2024
128
0.210
Why?
Receptors, Vasopressin
2
2021
20
0.210
Why?
Inappropriate ADH Syndrome
1
2023
8
0.210
Why?
Cysts
1
2024
113
0.200
Why?
Magnetic Resonance Imaging
3
2025
3566
0.200
Why?
Hyponatremia
1
2023
42
0.200
Why?
Fluorocarbons
1
2024
117
0.200
Why?
Longitudinal Studies
5
2024
2844
0.200
Why?
Malates
1
2022
7
0.190
Why?
Fumarates
1
2022
9
0.190
Why?
Consensus
2
2022
683
0.190
Why?
Threonine
1
2022
47
0.190
Why?
Mechanistic Target of Rapamycin Complex 1
1
2023
125
0.190
Why?
Carboxylic Acids
1
2022
34
0.190
Why?
Biopsy
2
2025
1129
0.190
Why?
Diabetes Mellitus, Experimental
1
2023
195
0.190
Why?
Phenylalanine
1
2022
68
0.190
Why?
Amino Acids
2
2024
497
0.190
Why?
Pathology, Clinical
1
2022
36
0.190
Why?
Rats
2
2024
5647
0.180
Why?
Chemokine CCL2
1
2022
115
0.180
Why?
Arizona
1
2021
81
0.180
Why?
Glycine
1
2022
176
0.180
Why?
Image Processing, Computer-Assisted
1
2025
752
0.170
Why?
Osmolar Concentration
2
2018
171
0.170
Why?
p-Aminohippuric Acid
1
2020
6
0.170
Why?
Oxidation-Reduction
1
2024
1060
0.170
Why?
Tryptophan
1
2022
183
0.170
Why?
Interleukin-18
1
2022
236
0.170
Why?
Multivariate Analysis
2
2014
1509
0.170
Why?
Furosemide
1
2020
37
0.170
Why?
Nephrosis
1
2020
6
0.170
Why?
Natriuretic Peptide, Brain
1
2021
99
0.170
Why?
Japan
5
2017
115
0.170
Why?
Asymptomatic Diseases
2
2019
89
0.170
Why?
Diabetic Neuropathies
1
2021
94
0.170
Why?
Transgender Persons
1
2023
186
0.160
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2024
201
0.160
Why?
Calcium Channel Blockers
1
2021
167
0.160
Why?
Sodium-Glucose Transporter 1
1
2019
11
0.160
Why?
Body Water
1
2019
21
0.160
Why?
Diabetic Foot
1
2019
24
0.160
Why?
Glycolysis
1
2021
321
0.160
Why?
Models, Biological
3
2016
1783
0.160
Why?
Glomerulonephritis
1
2019
47
0.150
Why?
Glycosides
1
2019
36
0.150
Why?
Blood Chemical Analysis
1
2019
99
0.150
Why?
Postmenopause
1
2021
366
0.150
Why?
Software
2
2025
665
0.150
Why?
beta 2-Microglobulin
1
2018
50
0.150
Why?
Proof of Concept Study
3
2025
78
0.150
Why?
Myocardial Contraction
1
2020
341
0.150
Why?
Endothelial Cells
1
2024
785
0.150
Why?
Body Temperature Regulation
1
2019
97
0.150
Why?
Microscopy, Polarization
1
2018
31
0.150
Why?
Carotid Intima-Media Thickness
1
2018
90
0.150
Why?
Child, Preschool
4
2025
11074
0.140
Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
42
0.140
Why?
Allopurinol
1
2018
63
0.140
Why?
Pharmaceutical Preparations
1
2020
179
0.140
Why?
Energy Metabolism
1
2024
922
0.140
Why?
Mice
5
2025
17787
0.140
Why?
Obesity, Metabolically Benign
1
2017
4
0.140
Why?
Weight Loss
2
2020
787
0.140
Why?
Prehypertension
1
2017
28
0.140
Why?
Glucose Tolerance Test
2
2019
366
0.140
Why?
Glomerulosclerosis, Focal Segmental
1
2017
47
0.140
Why?
Deamino Arginine Vasopressin
1
2016
12
0.130
Why?
Urinary Calculi
1
2017
12
0.130
Why?
Life Style
1
2019
490
0.130
Why?
Hyperthermia, Induced
1
2018
116
0.130
Why?
Ventricular Dysfunction, Left
1
2020
382
0.130
Why?
Peptide Fragments
1
2021
706
0.130
Why?
Magnetic Resonance Angiography
1
2018
240
0.130
Why?
Dehydration
1
2016
51
0.130
Why?
Blood Banks
1
2016
41
0.130
Why?
Precision Medicine
1
2020
429
0.130
Why?
Morbidity
1
2017
324
0.130
Why?
Gastrointestinal Microbiome
1
2024
697
0.130
Why?
Regional Blood Flow
1
2018
474
0.130
Why?
Cardiorespiratory Fitness
1
2017
55
0.130
Why?
Tomography, X-Ray Computed
2
2018
2691
0.130
Why?
Disease Models, Animal
5
2021
4295
0.130
Why?
Vasodilation
1
2020
499
0.130
Why?
Anti-Inflammatory Agents
1
2020
496
0.130
Why?
Cognition
1
2024
1153
0.120
Why?
Vitreoretinopathy, Proliferative
1
2016
14
0.120
Why?
Survival Rate
2
2017
1972
0.120
Why?
Logistic Models
3
2017
2074
0.120
Why?
Linear Models
2
2017
849
0.120
Why?
Heart Rate
1
2019
822
0.120
Why?
Echocardiography, Doppler
1
2016
108
0.120
Why?
Hot Temperature
1
2018
391
0.120
Why?
Filtration
1
2015
72
0.110
Why?
Liver Diseases
1
2018
315
0.110
Why?
Risk Assessment
4
2019
3457
0.110
Why?
Apolipoproteins
1
2014
33
0.110
Why?
Enzyme Inhibitors
1
2018
840
0.110
Why?
Blood Pressure Determination
1
2015
157
0.110
Why?
Purines
1
2015
176
0.110
Why?
Achievement
1
2014
58
0.110
Why?
Phenotype
1
2022
3196
0.110
Why?
Stress, Mechanical
1
2016
485
0.110
Why?
Immunity, Innate
1
2019
828
0.110
Why?
Primary Prevention
1
2015
196
0.100
Why?
Liver
2
2021
1943
0.100
Why?
Randomized Controlled Trials as Topic
1
2019
1477
0.100
Why?
Exercise Test
1
2016
625
0.100
Why?
Adenosine Triphosphate
1
2015
491
0.100
Why?
Biomechanical Phenomena
1
2016
810
0.100
Why?
Research Design
1
2019
1139
0.100
Why?
Cholesterol
1
2014
410
0.100
Why?
United States
3
2024
14841
0.100
Why?
Antihypertensive Agents
1
2016
494
0.090
Why?
Aged, 80 and over
3
2018
7635
0.090
Why?
Retrospective Studies
8
2025
15657
0.090
Why?
RNA, Messenger
1
2019
2833
0.090
Why?
Regression Analysis
1
2014
1024
0.090
Why?
Feasibility Studies
1
2015
956
0.090
Why?
Vascular Diseases
1
2013
243
0.090
Why?
Exercise
1
2022
2057
0.090
Why?
Ambulatory Care
1
2015
546
0.090
Why?
Societies, Medical
1
2015
820
0.080
Why?
Hematocrit
2
2021
96
0.080
Why?
Gene Expression Regulation
1
2019
2607
0.080
Why?
Practice Guidelines as Topic
1
2017
1587
0.080
Why?
Fructokinases
2
2021
32
0.080
Why?
Registries
1
2016
2035
0.070
Why?
Inflammation
2
2021
2837
0.070
Why?
Prevalence
3
2019
2734
0.070
Why?
Reproducibility of Results
1
2015
3284
0.070
Why?
Fibrosis
2
2021
552
0.060
Why?
Infant
2
2025
9465
0.060
Why?
Postprandial Period
1
2025
107
0.060
Why?
Pregnancy
1
2017
6763
0.060
Why?
Isoleucine
1
2024
15
0.050
Why?
Valine
1
2024
82
0.050
Why?
Obesity, Abdominal
1
2024
48
0.050
Why?
Mice, Inbred C57BL
3
2021
5757
0.050
Why?
Aging
1
2014
1864
0.050
Why?
Antibodies
1
2025
410
0.050
Why?
Bromocriptine
1
2022
30
0.050
Why?
Multicenter Studies as Topic
1
2024
310
0.050
Why?
RNA, Transfer
1
2024
138
0.050
Why?
Infant, Newborn
1
2014
6079
0.050
Why?
Benzbromarone
1
2022
1
0.050
Why?
Environmental Pollutants
1
2024
159
0.050
Why?
Aldosterone
1
2022
45
0.050
Why?
Cytokines
2
2021
2085
0.050
Why?
Glycoproteins
1
2024
342
0.050
Why?
Controlled Clinical Trials as Topic
1
2021
30
0.050
Why?
Adenine
1
2023
271
0.050
Why?
Clinical Trials, Phase III as Topic
1
2021
106
0.050
Why?
Inulin
1
2021
7
0.040
Why?
Hep G2 Cells
1
2021
67
0.040
Why?
Drinking
1
2021
42
0.040
Why?
Serum Albumin
1
2021
150
0.040
Why?
Uricosuric Agents
1
2020
2
0.040
Why?
Diuretics, Osmotic
1
2020
2
0.040
Why?
TOR Serine-Threonine Kinases
1
2023
412
0.040
Why?
Mendelian Randomization Analysis
1
2020
50
0.040
Why?
Cell Hypoxia
1
2021
226
0.040
Why?
Cross-Over Studies
1
2022
564
0.040
Why?
Diastole
1
2020
149
0.040
Why?
Chemokines
1
2021
228
0.040
Why?
Systole
1
2020
189
0.040
Why?
Cytoprotection
1
2019
56
0.040
Why?
Environmental Exposure
1
2024
579
0.040
Why?
Netherlands
1
2019
88
0.040
Why?
Neuropsychological Tests
1
2024
1023
0.040
Why?
Drug Interactions
1
2021
410
0.040
Why?
Length of Stay
1
2025
1215
0.040
Why?
Preoperative Period
1
2019
129
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2020
193
0.040
Why?
Critical Illness
1
2025
811
0.040
Why?
Cognitive Dysfunction
1
2024
383
0.040
Why?
Incretins
1
2018
22
0.040
Why?
Macular Edema
1
2018
43
0.040
Why?
Photography
1
2018
96
0.040
Why?
Renal Elimination
1
2018
6
0.040
Why?
Inflammation Mediators
1
2021
513
0.040
Why?
Xanthine Oxidase
1
2018
81
0.040
Why?
HSP70 Heat-Shock Proteins
1
2018
73
0.030
Why?
Diet Therapy
1
2018
37
0.030
Why?
Renal Dialysis
1
2021
435
0.030
Why?
Cardiovascular System
1
2019
137
0.030
Why?
Anti-Obesity Agents
1
2018
57
0.030
Why?
Lipoproteins, LDL
1
2017
116
0.030
Why?
Renal Plasma Flow, Effective
1
2016
1
0.030
Why?
Blood Urea Nitrogen
1
2016
54
0.030
Why?
Blood Pressure Monitoring, Ambulatory
1
2017
85
0.030
Why?
Thiazolidinediones
1
2018
137
0.030
Why?
Tomography, Optical Coherence
1
2018
213
0.030
Why?
Aldehyde Reductase
1
2016
29
0.030
Why?
Water-Electrolyte Balance
1
2016
34
0.030
Why?
Infusions, Intravenous
1
2018
413
0.030
Why?
Ammonia
1
2016
62
0.030
Why?
Interleukin-6
1
2021
778
0.030
Why?
Proportional Hazards Models
1
2019
1266
0.030
Why?
Age Distribution
1
2017
392
0.030
Why?
Sex Distribution
1
2017
375
0.030
Why?
Collagen
1
2018
452
0.030
Why?
Waist Circumference
1
2015
143
0.030
Why?
Combined Modality Therapy
1
2018
1236
0.030
Why?
Blood Glucose Self-Monitoring
1
2019
641
0.030
Why?
Mice, Knockout
1
2021
3015
0.030
Why?
Circadian Rhythm
1
2017
468
0.030
Why?
Complement Activation
1
2016
415
0.030
Why?
Exercise Therapy
1
2018
443
0.030
Why?
Heart Ventricles
1
2018
788
0.020
Why?
Gene-Environment Interaction
1
2014
192
0.020
Why?
Comorbidity
1
2017
1622
0.020
Why?
Rats, Sprague-Dawley
1
2017
2486
0.020
Why?
Peptides
1
2018
985
0.020
Why?
Models, Statistical
1
2015
669
0.020
Why?
Databases, Factual
1
2017
1357
0.020
Why?
Non-alcoholic Fatty Liver Disease
1
2014
279
0.020
Why?
Algorithms
1
2015
1704
0.020
Why?
Hospitalization
1
2017
2199
0.020
Why?
Neoplasms
1
2014
2671
0.010
Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)